Ambipar Emergency Response Warrants
AMBI.WS
AMBI.WS was delisted on the 28th of October, 2025.
12 hedge funds and large institutions have $1,000K invested in Ambipar Emergency Response Warrants in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.07% less ownership
Funds ownership: 6.92% → 6.85% (-0.07%)
16% less capital invested
Capital invested by funds: $1.19M → $1,000K (-$188K)
20% less funds holding
Funds holding: 15 → 12 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$10K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$311 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$36 |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8 |
AMBI.WS Hedge Fund Activity: Q1 2025 in Review
12 of the 7,462 institutional investors tracked by Wall St. Rank reported a position in Ambipar Emergency Response Warrants (AMBI.WS) for Q1 2025, worth a combined $1,000K — down 16% from $1.19M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of AMBI.WS and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was HRT Financial, exiting entirely with an estimated $10K sold.
- 12 institutional investors held Ambipar Emergency Response Warrants (AMBI.WS) as of Q1 2025, down from 15 in Q4 2024.
- Funds reported $1,000K of Ambipar Emergency Response Warrants stock for Q1 2025, down 16% quarter-over-quarter.
- 0 funds opened new Ambipar Emergency Response Warrants positions in Q1 2025 and 3 closed out, a net change of -3 holders.
- The largest Ambipar Emergency Response Warrants seller in Q1 2025 was HRT Financial, an estimated $10K sold.
Based on aggregated 13F filings for Q1 2025.